Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octreotide LAR in Treatment Naïve Acromegaly
NCT00128232Phase 3Completed
- Sponsor
- Novartis
- Start
- Dec 2002
- Primary completion
- Aug 2004
- Modality
- Peptides
01
Overview
A Phase 3 trial of octreotide in acromegaly, sponsored by Novartis. Started Dec 2002; status: completed.
02
Drugs
octreotide
03
Conditions
acromegaly
Beyond the preview
Go deeper on NCT00128232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00128232.